You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Boehringer Ingelheim
Merck
Colorcon
McKinsey

Last Updated: March 31, 2020

DrugPatentWatch Database Preview

Pindolol - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for pindolol and what is the scope of freedom to operate?

Pindolol is the generic ingredient in two branded drugs marketed by Acp Nimble, Ani Pharms Inc, Bayshore Pharms Llc, Mylan Pharms Inc, Nostrum Labs, Nostrum Labs Inc, Purepac Pharm, Sun Pharm Industries, Watson Labs, Zydus Pharms, and Novartis, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for pindolol. Seven suppliers are listed for this compound.

Drug Prices for pindolol

See drug prices for pindolol

Recent Clinical Trials for pindolol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institutes of Health (NIH)Phase 2
University of FloridaPhase 2
Rho, Inc.Phase 2

See all pindolol clinical trials

Pharmacology for pindolol
Medical Subject Heading (MeSH) Categories for pindolol
Synonyms for pindolol
(.+/-.)-Pindolol
(+-)-Pindolol
(+/-)-1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
(+/-)-Pindolol-d7(iso-propyl-d7)
(1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol
(R,S)-PINDOLOL
1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol
1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol
1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol
1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol
1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #
1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol
1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol
1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol
1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol)
1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol)
1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol
1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol
1-[(1H-Indol-4-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol
1-[1H-INDOL-4-YLOXY]-3-[ISOPROPYLAMINO]-2-PROPANOL
13523-86-9
2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-
2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-
2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-
2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-
2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-
3-indol-4-yloxy-1-[(methylethyl)amino]propan-2-ol
4-(2-Hydroxy-3-isopropylaminopropoxy)-indole
4-(3-(Isopropylamino)-2-hydroxypropoxy)indole
5-21-03-00017 (Beilstein Handbook Reference)
523P869
AB00052072
AB00052072_12
AB00052072_13
AB00052072-11
AKOS015969756
BDBM50019443
Betapindol
Blockin L
Blocklin
Blocklin L
Blocklin-L
Blocklin-L (TN)
BPBio1_000022
BRD-A97701745-001-05-3
BRD-A97701745-001-09-5
BRN 1536506
BSPBio_000020
BSPBio_002193
C07445
Calvisken
Carvisken
Carvisken (TN)
CAS-13523-86-9
CCG-39223
CCRIS 9215
CHEBI:8214
CHEMBL500
CPD000059120
CS-4473
CTK8G2432
D00513
DB00960
Decreten
DivK1c_000837
DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole
DL-LB 46
DL-Pindolol
DSSTox_CID_3476
DSSTox_GSID_23476
DSSTox_RID_77043
DTXSID8023476
Durapindol
EINECS 236-867-9
EINECS 244-623-8
EU-0100955
FT-0630406
Glauco-visken
Glauco-Viskin
GTPL91
HMS1568A22
HMS1920H16
HMS2089I21
HMS2091P20
HMS2095A22
HMS3259I07
HMS3262P12
HMS3267K17
HMS3369E14
HMS3414J03
HMS3678H21
HMS3712A22
HMS3742C07
HMS502J19
HSDB 6539
HY-B0982
IDI1_000837
JZQKKSLKJUAGIC-UHFFFAOYSA-N
KBio1_000837
KBio2_001589
KBio2_004157
KBio2_006725
KBio3_001693
KBioGR_000958
KBioSS_001589
L000006
LB 46
LB-46
Lopac0_000955
LP00955
LS-122385
MCULE-7764948919
MFCD00010530
MLS000069496
MLS002548891
NC00467
NCGC00015786-06
NCGC00015786-07
NCGC00015786-08
NCGC00015786-09
NCGC00015786-10
NCGC00015786-11
NCGC00015786-13
NCGC00015786-14
NCGC00015786-16
NCGC00015786-20
NCGC00024925-03
NCGC00024925-04
NCGC00024925-05
NCGC00024925-06
NCGC00024925-07
NCGC00261640-01
NINDS_000837
NSC-757276
NSC757276
Oprea1_770884
P 0778
P-6820
PDSP1_000771
PDSP1_000772
PDSP2_000759
PDSP2_000760
Pectobloc
Pharmakon1600-01500488
Pinbetol
Pindolol (JP17/USP/INN)
Pindolol [USAN:INN:BAN:JAN]
Pindolol [USAN:USP:INN:BAN:JAN]
Pindolol, >=98% (TLC), powder
Pindolol, European Pharmacopoeia (EP) Reference Standard
Pindolol, United States Pharmacopeia (USP) Reference Standard
PINDOLOL,(-)
Pindololum
Pindololum [INN-Latin]
Prestwick_397
Prestwick0_000090
Prestwick1_000090
Prestwick2_000090
Prestwick3_000090
Prindolol
Prinodolol
Pynastin
Q418101
SAM002264631
SBI-0050929.P004
SC-25688
SCHEMBL5219
SMR000059120
SPBio_001289
SPBio_001959
Spectrum_001109
SPECTRUM1500488
Spectrum2_001285
Spectrum3_000547
Spectrum4_000479
Spectrum5_001266
SR-01000000027
SR-01000000027-2
SR-01000000027-4
SR-01000000027-5
SR-01000000027-7
ST50319990
SW196641-3
Tox21_110221
Tox21_110221_1
Tox21_500955
Visken
Visken (TN)
Z3376

US Patents and Regulatory Information for pindolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acp Nimble PINDOLOL pindolol TABLET;ORAL 073661-002 Oct 31, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc PINDOLOL pindolol TABLET;ORAL 074019-002 Sep 3, 1992 AB RX No Yes   Start Trial   Start Trial   Start Trial
Ani Pharms Inc PINDOLOL pindolol TABLET;ORAL 073609-001 Mar 29, 1993 AB RX No No   Start Trial   Start Trial   Start Trial
Nostrum Labs PINDOLOL pindolol TABLET;ORAL 074474-001 Oct 28, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Acp Nimble PINDOLOL pindolol TABLET;ORAL 073687-001 Feb 26, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms PINDOLOL pindolol TABLET;ORAL 209866-001 Aug 18, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Boehringer Ingelheim
Merck
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.